# A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066

> **NCT01250730** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-02341066
- **DRUG:** PF-02341066
- **DRUG:** PF-02341066

## Key facts

- **NCT ID:** NCT01250730
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250730, "A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01250730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*